[Puluo Pharmaceutical: Net profit in the first three quarters fell 12.37% year-on-year] On October 22, Prolu Pharmaceutical (000739.SZ) announced that it achieved operating income of 6.835 billion yuan in the first three quarters, a year-on-year decrease of 11.97%; the net profit attributable to shareholders of listed companies was 614 million yuan, a year-on-year decrease of 12.37%. Operating income in the third quarter was 2.011 billion yuan, a year-on-year decrease of 13.28%; net profit attributable to shareholders of listed companies was 91.2934 million yuan, a year-on-year decrease of 33.47%. Xiaocai Note: The company’s Q3 net profit was 91 million, and Q2 net profit was 273 million. Based on this calculation, Q3 net profit fell 66% month-on-month.